Profile change history

What changed for Pemvidutide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Pemvidutide identity.

5Total events
4Record additions
1Version changes
1Cited source years

Before and after

Preserved version changes

Profile updated

Pemvidutide profile

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change.

PeptideScanner change date
July 27, 2026
Evidence lane
Profile

Profile summary

Before
A glucagon/GLP-1 receptor agonist candidate with trial-registry records.
After
A glucagon/GLP-1 receptor agonist candidate. This profile cites a completed ClinicalTrials.gov study record.

Collection chronology

Evidence added to PeptideScanner

Browse all 4 connected records →

Showing the latest 4 additions by PeptideScanner publication date; the complete connected record set remains available in Latest Research. Most recent addition: August 14, 2026.

Record added

ClinicalTrials.gov record NCT06987513

PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide.

PeptideScanner change date
August 14, 2026
Cited source date
July 31, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07009860

PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide.

PeptideScanner change date
August 14, 2026
Cited source date
March 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05989711

PeptideScanner retained ClinicalTrials.gov record NCT05989711 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was pemvidutide.

PeptideScanner change date
August 9, 2026
Cited source date
May 18, 2026
Evidence lane
Clinical trials